Romain Fournier

Chief Editor
Having worked in the British, French and Swiss financial press, Romain is able to report on local and international issues, as comfortable in French as in the language of Shakespeare, Romain Fournier leads the editorial team at Marketscreener. Fine connoisseur of the English-speaking markets, Romain delivers an editorial every day on US and UK markets.

Analyst recommendations: Anglo American, Pfizer, Rolls-Royce, Nike, Oatly...

06/15/2021 | 06:22am EDT

RBC is interested in the rising stars of alternative energies such as ITM Power, while also upgrading Anglo American from Outperform to Sector Perform. JPMorgan significantly raises Biogen's price target, thanks to the company's new treatment against Alzheimer.



  • Anglo American: RBC upgrades from Outperform to Sector Perform with a target of GBp3,400.
  • AstraZeneca: Berenberg advises its customers to buy the stock. The target price is still set at GBp 95.
  • Auto Trader: Berenberg remains Hold with a price target raised from GBp 520 to GBp 650.
  • Biogen : JPMorgan adjusts pt to $435 from $269, maintains neutral rating
  • GlaxoSmithKline: Berenberg is positive on the stock with a Buy rating. The target price is still set at GBp 1570.
  • ITM Power: RBC starts tracking at sector perform, targeting GBp 310.
  • John Laing: HSBC upgraded from buy to hold, targeting GBP 403.
  • Pagegroup: Morgan Stanley upgraded from Overweight to Underweight, targeting GBP 545. 
  • Pfizer: Berenberg is keeping its Neutral rating. The target price is unchanged at USD 43.
  • Procore Technologies : Oppenheimer initiates coverage with outperform rating, $100 price target
  • RAPT Therapeutics : Cantor Fitzgerald hikes pt to $71 from $51 atopic dermatitis treatment results, keeps overweight rating
  • Rolls-Royce: Berenberg still considers the stock as a Buy opportunity. The target price is unchanged and still at GBp 150.
  • Nike: UBS retains his positive opinion on the stock with a Buy rating. The target price is set at USD 170 versus USD 175.
  • Oatly : Barclays initiates at overweight rating with $34 price target
  • The Boeing Company: Berenberg's research confirms its neutral opinion on the stock. The target price has been raised from USD 215 to USD 245.
  • United Airlines : Citigroup adjusts price target to $67 from $65, keeps buy rating

© 2021
Stocks mentioned in the article
ChangeLast1st jan.
ADLER GROUP S.A. -10.73% 3.296 Delayed Quote.-66.13%
AIR LIQUIDE -0.53% 135.5 Real-time Quote.-2.01%
AIRBUS SE -2.17% 108.14 Real-time Quote.-1.62%
ANGLO AMERICAN PLC -1.20% 2966.5 Delayed Quote.-0.45%
ANHEUSER-BUSCH INBEV SA/NV -0.88% 53.03 Real-time Quote.0.62%
ASTRAZENECA PLC 0.31% 11002 Delayed Quote.26.39%
AUTO TRADER GROUP PLC 0.06% 658.4 Delayed Quote.-11.08%
BARCLAYS PLC -1.07% 168.68 Delayed Quote.-8.82%
BELIMO HOLDING AG -1.15% 387.5 Delayed Quote.-32.41%
BIOGEN INC. -0.77% 218.06 Delayed Quote.-8.45%
CITIGROUP INC. -1.18% 53.575 Delayed Quote.-10.28%
DUFRY AG -0.68% 39.55 Delayed Quote.-11.81%
GSK PLC -0.67% 1415.4 Delayed Quote.-29.04%
HSBC HOLDINGS PLC -0.85% 545.1 Delayed Quote.22.55%
INPOST S.A. -4.46% 5.956 Real-time Quote.-41.18%
ITM POWER PLC -0.94% 242.2 Delayed Quote.-37.94%
JPMORGAN CHASE & CO. -1.32% 122 Delayed Quote.-21.93%
MORGAN STANLEY -0.97% 91.015 Delayed Quote.-6.46%
MTU AERO ENGINES AG -1.14% 195.9 Delayed Quote.10.45%
NEL ASA -1.01% 15.69 Real-time Quote.4.21%
NIKE, INC. -1.24% 116.69 Delayed Quote.-29.17%
OATLY GROUP AB -6.07% 3.745 Delayed Quote.-49.87%
PAGEGROUP PLC 0.04% 445 Delayed Quote.-29.79%
PFIZER, INC. -0.56% 49.61 Delayed Quote.-15.56%
PROCORE TECHNOLOGIES, INC. -2.74% 61.38 Delayed Quote.-21.12%
RAPT THERAPEUTICS, INC. -1.55% 28.63 Delayed Quote.-20.83%
ROLLS-ROYCE HOLDINGS PLC -2.79% 83.5 Delayed Quote.-30.09%
SAFRAN -0.75% 111.62 Real-time Quote.4.46%
SOITEC -3.84% 155.2 Real-time Quote.-25.00%
THE BOEING COMPANY -3.41% 166.48 Delayed Quote.-14.52%
UBS GROUP AG -1.06% 15.905 Delayed Quote.-2.10%
UNITED AIRLINES HOLDINGS, INC. -4.24% 38.64 Delayed Quote.-7.97%
YARA INTERNATIONAL ASA -0.14% 422.7 Real-time Quote.-4.88%